市場調査レポート

商品コード

1117709

世界の抗血栓薬市場：考察と予測 (2028年まで)

Global Antithrombotic Drugs Market Insights, Forecast to 2028

出版日: 2022年08月23日 | 発行: QYResearch

| ページ情報: 英文 120 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 773,710円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,160,565円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,547,420円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、抗血栓薬 (Antithrombotic Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

抗血栓薬の製品概要
市場：タイプ別
- 世界の抗血栓薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Apixaban
- Debigatran
- Edoxaban
- Fondaparinux
- Heparin
- Rivaroxaban
市場：アプリケーション別
- 世界の抗血栓薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- General Pharmacies
- Hospital Pharmacies
- Online Retailers
- Drug Stores
調査目的
対象期間

第2章レポート概要

世界の抗血栓薬の販売推定および予測 2017-2028
世界の抗血栓薬の収益推定および予測 2017-2028
世界の抗血栓薬の収益：地域別: 2017 VS 2021 VS 2028
世界の抗血栓薬の販売：地域別
- 世界の抗血栓薬の販売：地域別 (2017-2022)
- 世界の販売抗血栓薬：地域別 (2023-2028)
世界の抗血栓薬の収益：地域別
- 世界の抗血栓薬の収益：地域別 (2017-2022)
- 世界の抗血栓薬の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界の抗血栓薬の販売：メーカー別
- 世界の抗血栓薬の上位メーカー：販売別 (2017-2022)
- 世界の抗血栓薬の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：抗血栓薬2021
世界の抗血栓薬の収益：メーカー別
- 世界の抗血栓薬の収益：メーカー別 (2017-2022)
- 世界の抗血栓薬の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：抗血栓薬の収益 2021
世界の抗血栓薬の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界の抗血栓薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界の抗血栓薬のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界の抗血栓薬の販売：タイプ別
- 世界の抗血栓薬の販売実績：タイプ別 (2017-2022)
- 世界の抗血栓薬の販売予測：タイプ別 (2023-2028)
- 世界の抗血栓薬の販売市場シェア：タイプ別 (2017-2028)
世界の抗血栓薬の収益：タイプ別
- 世界の抗血栓薬の収益実績：タイプ別 (2017-2022)
- 世界の抗血栓薬の収益予測：タイプ別 (2023-2028)
- 世界の抗血栓薬の収益市場シェア：タイプ別 (2017-2028)
世界の抗血栓薬の価格：タイプ別
- 世界の抗血栓薬の価格：タイプ別 (2017-2022)
- 世界の抗血栓薬の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界の抗血栓薬の販売：アプリケーション別
- 世界の抗血栓薬の販売実績：アプリケーション別 (2017-2022)
- 世界の抗血栓薬の販売予測：アプリケーション別 (2023-2028)
- 世界の抗血栓薬の販売市場シェア：アプリケーション別 (2017-2028)
世界の抗血栓薬の収益：アプリケーション別
- 世界の抗血栓薬の収益実績：アプリケーション別 (2017-2022)
- 世界の抗血栓薬の収益予測：アプリケーション別 (2023-2028)
- 世界の抗血栓薬の収益市場シェア：アプリケーション別 (2017-2028)
世界の抗血栓薬の価格：アプリケーション別
- 世界の抗血栓薬の価格：アプリケーション別 (2017-2022)
- 世界の抗血栓薬の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米の抗血栓薬市場規模：タイプ別
- 北米の抗血栓薬の販売：タイプ別 (2017-2028)
- 北米の抗血栓薬の収益：タイプ別 (2017-2028)
北米の抗血栓薬市場規模：アプリケーション別
- 北米の抗血栓薬の販売：アプリケーション別 (2017-2028)
- 北米の抗血栓薬の収益：アプリケーション別 (2017-2028)
北米の抗血栓薬市場規模：国別
- 北米の抗血栓薬の販売：国別 (2017-2028)
- 北米の抗血栓薬の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州の抗血栓薬市場規模：タイプ別
- 欧州の抗血栓薬の販売：タイプ別 (2017-2028)
- 欧州の抗血栓薬の収益：タイプ別 (2017-2028)
欧州の抗血栓薬市場規模：アプリケーション別
- 欧州の抗血栓薬の販売：アプリケーション別 (2017-2028)
- 欧州の抗血栓薬の収益：アプリケーション別 (2017-2028)
欧州の抗血栓薬市場規模：国別
- 欧州の抗血栓薬の販売：国別 (2017-2028)
- 欧州の抗血栓薬の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋の抗血栓薬市場規模：タイプ別
- アジア太平洋の抗血栓薬の販売：タイプ別 (2017-2028)
- アジア太平洋の抗血栓薬の収益：タイプ別 (2017-2028)
アジア太平洋の抗血栓薬市場規模：アプリケーション別
- アジア太平洋の抗血栓薬の販売：アプリケーション別 (2017-2028)
- アジア太平洋の抗血栓薬の収益：アプリケーション別 (2017-2028)
アジア太平洋の抗血栓薬市場規模：地域別
- アジア太平洋の抗血栓薬の販売：地域別 (2017-2028)
- アジア太平洋の抗血栓薬の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア
- フィリピン

第9章ラテンアメリカ

ラテンアメリカの抗血栓薬市場規模：タイプ別
- ラテンアメリカの抗血栓薬の販売：タイプ別 (2017-2028)
- ラテンアメリカの抗血栓薬の収益：タイプ別 (2017-2028)
ラテンアメリカの抗血栓薬市場規模：アプリケーション別
- ラテンアメリカの抗血栓薬の販売：アプリケーション別 (2017-2028)
- ラテンアメリカの抗血栓薬の収益：アプリケーション別 (2017-2028)
ラテンアメリカの抗血栓薬市場規模：国別
- ラテンアメリカの抗血栓薬の販売：国別 (2017-2028)
- ラテンアメリカの抗血栓薬の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン

第10章中東・アフリカ

中東・アフリカの抗血栓薬市場規模：タイプ別
- 中東・アフリカの抗血栓薬の販売：タイプ別 (2017-2028)
- 中東・アフリカの抗血栓薬の収益：タイプ別 (2017-2028)
中東・アフリカの抗血栓薬市場規模：アプリケーション別
- 中東・アフリカの抗血栓薬の販売：アプリケーション別 (2017-2028)
- 中東・アフリカの抗血栓薬の収益：アプリケーション別 (2017-2028)
中東・アフリカの抗血栓薬市場規模：国別
- 中東・アフリカの抗血栓薬の販売：国別 (2017-2028)
- 中東・アフリカの抗血栓薬の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

Bristol myers squibb pharma
Abbott laboratories
Pliva
Sandoz
Pfizer
Pharmacia
Watson laboratories
Zydus pharmaceuticals usa
Bristol-Myers Squibb

第12章業界チェーンと販売チャネルの分析

抗血栓薬業界チェーン分析
抗血栓薬主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
抗血栓薬生産形態とプロセス
抗血栓薬販売およびマーケティング
- 抗血栓薬販売チャネル
- 抗血栓薬卸業者
抗血栓薬顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

抗血栓薬業界動向
抗血栓薬市場の促進要因
抗血栓薬市場の課題
抗血栓薬市場の抑制要因

第14章世界の抗血栓薬の主な市場調査結果

第15章付録

図表

Table 1. Global Antithrombotic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Apixaban
Table 3. Major Manufacturers of Debigatran
Table 4. Major Manufacturers of Edoxaban
Table 5. Major Manufacturers of Fondaparinux
Table 6. Major Manufacturers of Heparin
Table 7. Major Manufacturers of Rivaroxaban
Table 8. Global Antithrombotic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Antithrombotic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Antithrombotic Drugs Sales by Region (2017-2022) & (K Pcs)
Table 11. Global Antithrombotic Drugs Sales Market Share by Region (2017-2022)
Table 12. Global Antithrombotic Drugs Sales by Region (2023-2028) & (K Pcs)
Table 13. Global Antithrombotic Drugs Sales Market Share by Region (2023-2028)
Table 14. Global Antithrombotic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Antithrombotic Drugs Revenue Market Share by Region (2017-2022)
Table 16. Global Antithrombotic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Antithrombotic Drugs Revenue Market Share by Region (2023-2028)
Table 18. Global Antithrombotic Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global Antithrombotic Drugs Sales Share by Manufacturers (2017-2022)
Table 20. Global Antithrombotic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Antithrombotic Drugs Revenue Share by Manufacturers (2017-2022)
Table 22. Antithrombotic Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global Antithrombotic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Antithrombotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombotic Drugs as of 2021)
Table 25. Antithrombotic Drugs Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Antithrombotic Drugs Product Offered
Table 27. Date of Manufacturers Enter into Antithrombotic Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Antithrombotic Drugs Sales by Type (2017-2022) & (K Pcs)
Table 30. Global Antithrombotic Drugs Sales by Type (2023-2028) & (K Pcs)
Table 31. Global Antithrombotic Drugs Sales Share by Type (2017-2022)
Table 32. Global Antithrombotic Drugs Sales Share by Type (2023-2028)
Table 33. Global Antithrombotic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Antithrombotic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Antithrombotic Drugs Revenue Share by Type (2017-2022)
Table 36. Global Antithrombotic Drugs Revenue Share by Type (2023-2028)
Table 37. Antithrombotic Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global Antithrombotic Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global Antithrombotic Drugs Sales by Application (2017-2022) & (K Pcs)
Table 40. Global Antithrombotic Drugs Sales by Application (2023-2028) & (K Pcs)
Table 41. Global Antithrombotic Drugs Sales Share by Application (2017-2022)
Table 42. Global Antithrombotic Drugs Sales Share by Application (2023-2028)
Table 43. Global Antithrombotic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Antithrombotic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Antithrombotic Drugs Revenue Share by Application (2017-2022)
Table 46. Global Antithrombotic Drugs Revenue Share by Application (2023-2028)
Table 47. Antithrombotic Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global Antithrombotic Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America Antithrombotic Drugs Sales by Type (2017-2022) & (K Pcs)
Table 50. North America Antithrombotic Drugs Sales by Type (2023-2028) & (K Pcs)
Table 51. North America Antithrombotic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Antithrombotic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Antithrombotic Drugs Sales by Application (2017-2022) & (K Pcs)
Table 54. North America Antithrombotic Drugs Sales by Application (2023-2028) & (K Pcs)
Table 55. North America Antithrombotic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Antithrombotic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Antithrombotic Drugs Sales by Country (2017-2022) & (K Pcs)
Table 58. North America Antithrombotic Drugs Sales by Country (2023-2028) & (K Pcs)
Table 59. North America Antithrombotic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Antithrombotic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Antithrombotic Drugs Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Antithrombotic Drugs Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe Antithrombotic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Antithrombotic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Antithrombotic Drugs Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe Antithrombotic Drugs Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe Antithrombotic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Antithrombotic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Antithrombotic Drugs Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe Antithrombotic Drugs Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe Antithrombotic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Antithrombotic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Antithrombotic Drugs Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific Antithrombotic Drugs Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific Antithrombotic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Antithrombotic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Antithrombotic Drugs Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific Antithrombotic Drugs Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific Antithrombotic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Antithrombotic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Antithrombotic Drugs Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific Antithrombotic Drugs Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific Antithrombotic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Antithrombotic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Antithrombotic Drugs Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America Antithrombotic Drugs Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America Antithrombotic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Antithrombotic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Antithrombotic Drugs Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America Antithrombotic Drugs Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America Antithrombotic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Antithrombotic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Antithrombotic Drugs Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America Antithrombotic Drugs Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America Antithrombotic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Antithrombotic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Antithrombotic Drugs Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Antithrombotic Drugs Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Antithrombotic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Antithrombotic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Antithrombotic Drugs Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Antithrombotic Drugs Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Antithrombotic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Antithrombotic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Antithrombotic Drugs Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa Antithrombotic Drugs Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa Antithrombotic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Antithrombotic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 109. Bristol myers squibb pharma Corporation Information
Table 110. Bristol myers squibb pharma Description and Major Businesses
Table 111. Bristol myers squibb pharma Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Bristol myers squibb pharma Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bristol myers squibb pharma Recent Developments
Table 114. Abbott laboratories Corporation Information
Table 115. Abbott laboratories Description and Major Businesses
Table 116. Abbott laboratories Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Abbott laboratories Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Abbott laboratories Recent Developments
Table 119. Pliva Corporation Information
Table 120. Pliva Description and Major Businesses
Table 121. Pliva Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Pliva Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Pliva Recent Developments
Table 124. Sandoz Corporation Information
Table 125. Sandoz Description and Major Businesses
Table 126. Sandoz Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Sandoz Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Sandoz Recent Developments
Table 129. Pfizer Corporation Information
Table 130. Pfizer Description and Major Businesses
Table 131. Pfizer Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Pfizer Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Pfizer Recent Developments
Table 134. Pharmacia Corporation Information
Table 135. Pharmacia Description and Major Businesses
Table 136. Pharmacia Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. Pharmacia Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Pharmacia Recent Developments
Table 139. Watson laboratories Corporation Information
Table 140. Watson laboratories Description and Major Businesses
Table 141. Watson laboratories Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Watson laboratories Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Watson laboratories Recent Developments
Table 144. Zydus pharmaceuticals usa Corporation Information
Table 145. Zydus pharmaceuticals usa Description and Major Businesses
Table 146. Zydus pharmaceuticals usa Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. Zydus pharmaceuticals usa Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Zydus pharmaceuticals usa Recent Developments
Table 149. Bristol-Myers Squibb Corporation Information
Table 150. Bristol-Myers Squibb Description and Major Businesses
Table 151. Bristol-Myers Squibb Antithrombotic Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 152. Bristol-Myers Squibb Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Bristol-Myers Squibb Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Antithrombotic Drugs Distributors List
Table 157. Antithrombotic Drugs Customers List
Table 158. Antithrombotic Drugs Market Trends
Table 159. Antithrombotic Drugs Market Drivers
Table 160. Antithrombotic Drugs Market Challenges
Table 161. Antithrombotic Drugs Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources

List of Figures

Figure 1. Antithrombotic Drugs Product Picture
Figure 3. Global Antithrombotic Drugs Market Share by Type in 2021 & 2028
Figure 3. Apixaban Product Picture
Figure 4. Debigatran Product Picture
Figure 5. Edoxaban Product Picture
Figure 6. Fondaparinux Product Picture
Figure 7. Heparin Product Picture
Figure 8. Rivaroxaban Product Picture
Figure 9. Global Antithrombotic Drugs Market Share by Application in 2021 & 2028
Figure 10. General Pharmacies
Figure 11. Hospital Pharmacies
Figure 12. Online Retailers
Figure 13. Drug Stores
Figure 14. Antithrombotic Drugs Report Years Considered
Figure 15. Global Antithrombotic Drugs Sales 2017-2028 (K Pcs)
Figure 16. Global Antithrombotic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Antithrombotic Drugs Revenue 2017-2028 (US$ Million)
Figure 18. Global Antithrombotic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Antithrombotic Drugs Sales Market Share by Region (2017-2022)
Figure 20. Global Antithrombotic Drugs Sales Market Share by Region (2023-2028)
Figure 21. North America Antithrombotic Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America Antithrombotic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Antithrombotic Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe Antithrombotic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Antithrombotic Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific Antithrombotic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Antithrombotic Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America Antithrombotic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Antithrombotic Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa Antithrombotic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Antithrombotic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Antithrombotic Drugs in the World: Market Share by Antithrombotic Drugs Revenue in 2021
Figure 33. Global Antithrombotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Antithrombotic Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Antithrombotic Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Antithrombotic Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
Figure 40. North America Antithrombotic Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
Figure 42. North America Antithrombotic Drugs Sales Share by Country (2017-2028)
Figure 43. North America Antithrombotic Drugs Revenue Share by Country (2017-2028)
Figure 44. U.S. Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Antithrombotic Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
Figure 48. Europe Antithrombotic Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
Figure 50. Europe Antithrombotic Drugs Sales Share by Country (2017-2028)
Figure 51. Europe Antithrombotic Drugs Revenue Share by Country (2017-2028)
Figure 52. Germany Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. France Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Antithrombotic Drugs Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Antithrombotic Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Antithrombotic Drugs Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Antithrombotic Drugs Revenue Share by Region (2017-2028)
Figure 63. China Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. India Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Antithrombotic Drugs Sales Market Share by Type (2017-2028)
Figure 74. Latin America Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Antithrombotic Drugs Sales Market Share by Application (2017-2028)
Figure 76. Latin America Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Antithrombotic Drugs Sales Share by Country (2017-2028)
Figure 78. Latin America Antithrombotic Drugs Revenue Share by Country (2017-2028)
Figure 79. Mexico Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Antithrombotic Drugs Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Antithrombotic Drugs Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Antithrombotic Drugs Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Antithrombotic Drugs Revenue Share by Country (2017-2028)
Figure 88. Turkey Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Antithrombotic Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. Antithrombotic Drugs Value Chain
Figure 92. Antithrombotic Drugs Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

This research report focuses on the Antithrombotic Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Antithrombotic Drugs Product Introduction
1.2 Market by Type
- 1.2.1 Global Antithrombotic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Apixaban
- 1.2.3 Debigatran
- 1.2.4 Edoxaban
- 1.2.5 Fondaparinux
- 1.2.6 Heparin
- 1.2.7 Rivaroxaban
1.3 Market by Application
- 1.3.1 Global Antithrombotic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 General Pharmacies
- 1.3.3 Hospital Pharmacies
- 1.3.4 Online Retailers
- 1.3.5 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Antithrombotic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Antithrombotic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Antithrombotic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antithrombotic Drugs Sales by Region
- 2.4.1 Global Antithrombotic Drugs Sales by Region (2017-2022)
- 2.4.2 Global Sales Antithrombotic Drugs by Region (2023-2028)
2.5 Global Antithrombotic Drugs Revenue by Region
- 2.5.1 Global Antithrombotic Drugs Revenue by Region (2017-2022)
- 2.5.2 Global Antithrombotic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Antithrombotic Drugs Sales by Manufacturers
- 3.1.1 Global Top Antithrombotic Drugs Manufacturers by Sales (2017-2022)
- 3.1.2 Global Antithrombotic Drugs Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antithrombotic Drugs in 2021
3.2 Global Antithrombotic Drugs Revenue by Manufacturers
- 3.2.1 Global Antithrombotic Drugs Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Antithrombotic Drugs Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Antithrombotic Drugs Revenue in 2021
3.3 Global Antithrombotic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Antithrombotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Antithrombotic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Antithrombotic Drugs Sales by Type
- 4.1.1 Global Antithrombotic Drugs Historical Sales by Type (2017-2022)
- 4.1.2 Global Antithrombotic Drugs Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Antithrombotic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Antithrombotic Drugs Revenue by Type
- 4.2.1 Global Antithrombotic Drugs Historical Revenue by Type (2017-2022)
- 4.2.2 Global Antithrombotic Drugs Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Antithrombotic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Antithrombotic Drugs Price by Type
- 4.3.1 Global Antithrombotic Drugs Price by Type (2017-2022)
- 4.3.2 Global Antithrombotic Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Antithrombotic Drugs Sales by Application
- 5.1.1 Global Antithrombotic Drugs Historical Sales by Application (2017-2022)
- 5.1.2 Global Antithrombotic Drugs Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Antithrombotic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Antithrombotic Drugs Revenue by Application
- 5.2.1 Global Antithrombotic Drugs Historical Revenue by Application (2017-2022)
- 5.2.2 Global Antithrombotic Drugs Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Antithrombotic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Antithrombotic Drugs Price by Application
- 5.3.1 Global Antithrombotic Drugs Price by Application (2017-2022)
- 5.3.2 Global Antithrombotic Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Antithrombotic Drugs Market Size by Type
- 6.1.1 North America Antithrombotic Drugs Sales by Type (2017-2028)
- 6.1.2 North America Antithrombotic Drugs Revenue by Type (2017-2028)
6.2 North America Antithrombotic Drugs Market Size by Application
- 6.2.1 North America Antithrombotic Drugs Sales by Application (2017-2028)
- 6.2.2 North America Antithrombotic Drugs Revenue by Application (2017-2028)
6.3 North America Antithrombotic Drugs Market Size by Country
- 6.3.1 North America Antithrombotic Drugs Sales by Country (2017-2028)
- 6.3.2 North America Antithrombotic Drugs Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada

7 Europe

7.1 Europe Antithrombotic Drugs Market Size by Type
- 7.1.1 Europe Antithrombotic Drugs Sales by Type (2017-2028)
- 7.1.2 Europe Antithrombotic Drugs Revenue by Type (2017-2028)
7.2 Europe Antithrombotic Drugs Market Size by Application
- 7.2.1 Europe Antithrombotic Drugs Sales by Application (2017-2028)
- 7.2.2 Europe Antithrombotic Drugs Revenue by Application (2017-2028)
7.3 Europe Antithrombotic Drugs Market Size by Country
- 7.3.1 Europe Antithrombotic Drugs Sales by Country (2017-2028)
- 7.3.2 Europe Antithrombotic Drugs Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Antithrombotic Drugs Market Size by Type
- 8.1.1 Asia Pacific Antithrombotic Drugs Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Antithrombotic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Antithrombotic Drugs Market Size by Application
- 8.2.1 Asia Pacific Antithrombotic Drugs Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Antithrombotic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Antithrombotic Drugs Market Size by Region
- 8.3.1 Asia Pacific Antithrombotic Drugs Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Antithrombotic Drugs Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines

9 Latin America

9.1 Latin America Antithrombotic Drugs Market Size by Type
- 9.1.1 Latin America Antithrombotic Drugs Sales by Type (2017-2028)
- 9.1.2 Latin America Antithrombotic Drugs Revenue by Type (2017-2028)
9.2 Latin America Antithrombotic Drugs Market Size by Application
- 9.2.1 Latin America Antithrombotic Drugs Sales by Application (2017-2028)
- 9.2.2 Latin America Antithrombotic Drugs Revenue by Application (2017-2028)
9.3 Latin America Antithrombotic Drugs Market Size by Country
- 9.3.1 Latin America Antithrombotic Drugs Sales by Country (2017-2028)
- 9.3.2 Latin America Antithrombotic Drugs Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Antithrombotic Drugs Market Size by Type
- 10.1.1 Middle East and Africa Antithrombotic Drugs Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Antithrombotic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Antithrombotic Drugs Market Size by Application
- 10.2.1 Middle East and Africa Antithrombotic Drugs Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Antithrombotic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Antithrombotic Drugs Market Size by Country
- 10.3.1 Middle East and Africa Antithrombotic Drugs Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Antithrombotic Drugs Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 Bristol myers squibb pharma
- 11.1.1 Bristol myers squibb pharma Corporation Information
- 11.1.2 Bristol myers squibb pharma Overview
- 11.1.3 Bristol myers squibb pharma Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Bristol myers squibb pharma Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Bristol myers squibb pharma Recent Developments
11.2 Abbott laboratories
- 11.2.1 Abbott laboratories Corporation Information
- 11.2.2 Abbott laboratories Overview
- 11.2.3 Abbott laboratories Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Abbott laboratories Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Abbott laboratories Recent Developments
11.3 Pliva
- 11.3.1 Pliva Corporation Information
- 11.3.2 Pliva Overview
- 11.3.3 Pliva Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Pliva Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Pliva Recent Developments
11.4 Sandoz
- 11.4.1 Sandoz Corporation Information
- 11.4.2 Sandoz Overview
- 11.4.3 Sandoz Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Sandoz Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Sandoz Recent Developments
11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Overview
- 11.5.3 Pfizer Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Pfizer Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Pfizer Recent Developments
11.6 Pharmacia
- 11.6.1 Pharmacia Corporation Information
- 11.6.2 Pharmacia Overview
- 11.6.3 Pharmacia Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 Pharmacia Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Pharmacia Recent Developments
11.7 Watson laboratories
- 11.7.1 Watson laboratories Corporation Information
- 11.7.2 Watson laboratories Overview
- 11.7.3 Watson laboratories Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Watson laboratories Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Watson laboratories Recent Developments
11.8 Zydus pharmaceuticals usa
- 11.8.1 Zydus pharmaceuticals usa Corporation Information
- 11.8.2 Zydus pharmaceuticals usa Overview
- 11.8.3 Zydus pharmaceuticals usa Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Zydus pharmaceuticals usa Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Zydus pharmaceuticals usa Recent Developments
11.9 Bristol-Myers Squibb
- 11.9.1 Bristol-Myers Squibb Corporation Information
- 11.9.2 Bristol-Myers Squibb Overview
- 11.9.3 Bristol-Myers Squibb Antithrombotic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Bristol-Myers Squibb Antithrombotic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Bristol-Myers Squibb Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Antithrombotic Drugs Industry Chain Analysis
12.2 Antithrombotic Drugs Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Antithrombotic Drugs Production Mode & Process
12.4 Antithrombotic Drugs Sales and Marketing
- 12.4.1 Antithrombotic Drugs Sales Channels
- 12.4.2 Antithrombotic Drugs Distributors
12.5 Antithrombotic Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Antithrombotic Drugs Industry Trends
13.2 Antithrombotic Drugs Market Drivers
13.3 Antithrombotic Drugs Market Challenges
13.4 Antithrombotic Drugs Market Restraints

14 Key Findings in The Global Antithrombotic Drugs Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

世界の抗血栓薬市場：考察と予測 (2028年まで)

Global Antithrombotic Drugs Market Insights, Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の抗血栓薬の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Antithrombotic Drugs Study

15 Appendix

世界の抗血栓薬市場：考察と予測 (2028年まで)

Global Antithrombotic Drugs Market Insights, Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界の抗血栓薬の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Antithrombotic Drugs Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の抗血栓薬の主な市場調査結果

第15章付録